Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)
Close on Nov 17, 2026Market cap $800.28MP/E –Yield –
Beta Bionics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Beta Bionics's price to sales ratio was 6.7× on Nov 11, 2026, against 15.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.7× | −8.4 |
| 2025 | Dec 31, 2025 | 15.1× | – |
See a number that looks wrong?